You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Polihexanide 0.8 mg/ml eye drops for treating acanthamoeba keratitis in people 12 years and over [ID6497]

  • In development
  • Reference number: GID-TA11643
  • Expected publication date: TBC
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Topic selection
  4. Notes
  5. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6497

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (online commenting)

  • Draft guidance (downloadable version) (PDF 309 KB)

    Published:
    13 February 2026
  • Equality impact assessment (PDF 126 KB)

    Published:
    13 February 2026
  • Committee papers - ACM1 (PDF 5 MB)

    Published:
    17 February 2026
  • Public committee slides - ACM1 (PDF 1.17 MB)

    Published:
    17 February 2026

Invitation to participate

  • Final scope (PDF 120 KB)

    Published:
    11 April 2025
  • Final stakeholder list (PDF 44 KB)

    Published:
    11 April 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 265 KB)

    Published:
    11 April 2025
  • Equality impact assessment (scoping) (PDF 100 KB)

    Published:
    11 April 2025

Topic selection

  • HST checklist (PDF 326 KB)

    Published:
    12 May 2025

Notes

  • Note

  • Note

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6497

  • Draft matrix post referral (PDF 42 KB)

    Published:
    06 February 2025
  • Draft scope post referral (PDF 95 KB)

    Published:
    06 February 2025
Back to top